244 related articles for article (PubMed ID: 16791640)
1. A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin.
Talib J; Beck JL; Ralph SF
J Biol Inorg Chem; 2006 Jul; 11(5):559-70. PubMed ID: 16791640
[TBL] [Abstract][Full Text] [Related]
2. Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry.
Beck JL; Ambahera S; Yong SR; Sheil MM; de Jersey J; Ralph SF
Anal Biochem; 2004 Feb; 325(2):326-36. PubMed ID: 14751268
[TBL] [Abstract][Full Text] [Related]
3. A method for studies on interactions between a gold-based drug and plasma proteins based on capillary electrophoresis with inductively coupled plasma mass spectrometry detection.
Nguyen TT; Østergaard J; Gammelgaard B
Anal Bioanal Chem; 2015 Nov; 407(28):8497-503. PubMed ID: 26329282
[TBL] [Abstract][Full Text] [Related]
4. Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation.
Hill DT; Isab AA; Griswold DE; DiMartino MJ; Matz ED; Figueroa AL; Wawro JE; DeBrosse C; Reiff WM; Elder RC; Jones B; Webb JW; Shaw CF
Inorg Chem; 2010 Sep; 49(17):7663-75. PubMed ID: 20704360
[TBL] [Abstract][Full Text] [Related]
5. Proton-linked bi- and tri-metallic gold cyanide complexes observed by ESI-MS spectrometry.
Yangyuoru PM; Webb JW; Shaw CF
J Inorg Biochem; 2008 Mar; 102(3):576-83. PubMed ID: 18255157
[TBL] [Abstract][Full Text] [Related]
6. Glutathionato-S-Gold(III) complexes formed as intermediates in the reduction of auricyanide by glutathione.
Yangyuoru PM; Webb JW; Shaw CF
J Inorg Biochem; 2008 Mar; 102(3):584-93. PubMed ID: 18255156
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
[TBL] [Abstract][Full Text] [Related]
8. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.
Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229
[TBL] [Abstract][Full Text] [Related]
9. 1H NMR of albumin in human blood plasma: drug binding and redox reactions at Cys34.
Christodoulou J; Sadler PJ; Tucker A
FEBS Lett; 1995 Nov; 376(1-2):1-5. PubMed ID: 8521951
[TBL] [Abstract][Full Text] [Related]
10. Redox and ligand exchange reactions of potential gold(I) and gold(III)-cyanide metabolites under biomimetic conditions.
Canumalla AJ; Al-Zamil N; Phillips M; Isab AA; Shaw CF
J Inorg Biochem; 2001 May; 85(1):67-76. PubMed ID: 11377697
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations.
Miyamura S; Imafuku T; Anraku M; Taguchi K; Yamasaki K; Tominaga Y; Maeda H; Ishima Y; Watanabe H; Otagiri M; Maruyama T
J Pharm Sci; 2016 Mar; 105(3):1043-9. PubMed ID: 26928399
[TBL] [Abstract][Full Text] [Related]
12. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation.
Aldini G; Regazzoni L; Orioli M; Rimoldi I; Facino RM; Carini M
J Mass Spectrom; 2008 Nov; 43(11):1470-81. PubMed ID: 18457351
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I).
Chircorian A; Barrios AM
Bioorg Med Chem Lett; 2004 Oct; 14(20):5113-6. PubMed ID: 15380210
[TBL] [Abstract][Full Text] [Related]
14. A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy.
Christodoulou J; Sadler PJ; Tucker A
Eur J Biochem; 1994 Oct; 225(1):363-8. PubMed ID: 7925457
[TBL] [Abstract][Full Text] [Related]
15. A new target for gold(I) compounds: glutathione-S-transferase inhibition by auranofin.
De Luca A; Hartinger CG; Dyson PJ; Lo Bello M; Casini A
J Inorg Biochem; 2013 Feb; 119():38-42. PubMed ID: 23183361
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Multispectroscopic Analysis on the Interaction and Corona Formation of Human Serum Albumin with Gold/Silver Alloy Nanoparticles.
Selva Sharma A; Ilanchelian M
J Phys Chem B; 2015 Jul; 119(30):9461-76. PubMed ID: 26106942
[TBL] [Abstract][Full Text] [Related]
17. Effects of coordination mode of 2-mercaptothiazoline on reactivity of Au(I) compounds with thiols and sulfur-containing proteins.
Abbehausen C; Manzano CM; Corbi PP; Farrell NP
J Inorg Biochem; 2016 Dec; 165():136-145. PubMed ID: 27293145
[TBL] [Abstract][Full Text] [Related]
18. (13)C, (31)P and (15)N NMR studies of the ligand exchange reactions of auranofin and chloro(triethylphosphine)gold(I) with thiourea.
Ahmad S; Isab AA
J Inorg Biochem; 2002 Jan; 88(1):44-52. PubMed ID: 11750024
[TBL] [Abstract][Full Text] [Related]
19. Determination of cyanide, in urine and gastric content, by electrospray ionization tandem mass spectrometry after direct flow injection of dicyanogold.
Minakata K; Nozawa H; Gonmori K; Suzuki M; Suzuki O
Anal Chim Acta; 2009 Sep; 651(1):81-4. PubMed ID: 19733739
[TBL] [Abstract][Full Text] [Related]
20. Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs.
Massai L; Grifagni D; De Santis A; Geri A; Cantini F; Calderone V; Banci L; Messori L
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
